MD/PhD student Christopher Behrer's research examines how to regulate pharmaceutical quality.

Three faculty selected as members of the 2023-2024 class of fellows for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program and the parallel Executive Leadership in Health Care Program.

A Conversation with Eleanora Lad, MD, PhD, associate professor of ophthalmology, about the recent clinical trials that led to the first drug approved the FDA to treat a devastating eye disease called Geographic Atrophy.

Four staff members from across the School of Medicine have been named recipients of the inaugural Dean’s Staff Awards.

A drug combination that shows little overall survival benefit in white men with advanced prostate cancer has a far greater effect in Black men with the disease, according to interim results from a study led by the Duke Cancer Institute.

Jane Gagliardi, MD, MHS, has been named the new Associate Dean for Learning Environment and Well-being, effective July 1.

An anonymous $5 million gift has established a Presidential Distinguished Chair Professorship in endocrinology in honor of Diana McNeill, MD.

Patients who had prolapse surgery for pelvic floor disorders do just as well when they resume physical activity soon after the procedure compared to patients who restrict activities.

During the pandemic, women aged 20-40 years old in the Southern United States experienced an increase in mental health challenges, tighter budgets, and a decrease in exercise, according to a study from Duke University School of Medicine published in the American Journal of Preventive Medicine Focus.

Sharena Ballard-Hart is the Senior Program Coordinator and HR Manager for the Brain Imaging and Analysis Center (BIAC). She also serves as the Equity, Diversity, and Inclusion (EDI) Leader for BIAC.